Arteris, Inc. (NASDAQ:AIP – Get Free Report) CEO K Charles Janac sold 7,823 shares of the stock in a transaction dated Friday, January 2nd. The stock was sold at an average price of $15.45, for a total transaction of $120,865.35. Following the completion of the transaction, the chief executive officer directly owned 150,632 shares of the company’s stock, valued at $2,327,264.40. This trade represents a 4.94% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.
K Charles Janac also recently made the following trade(s):
- On Tuesday, January 6th, K Charles Janac sold 11,145 shares of Arteris stock. The shares were sold at an average price of $16.90, for a total value of $188,350.50.
- On Monday, December 8th, K Charles Janac sold 70,000 shares of Arteris stock. The stock was sold at an average price of $17.71, for a total value of $1,239,700.00.
- On Friday, December 5th, K Charles Janac sold 60,000 shares of Arteris stock. The stock was sold at an average price of $17.08, for a total value of $1,024,800.00.
- On Thursday, December 4th, K Charles Janac sold 40,000 shares of Arteris stock. The shares were sold at an average price of $16.46, for a total value of $658,400.00.
- On Wednesday, December 3rd, K Charles Janac sold 2,058 shares of Arteris stock. The shares were sold at an average price of $15.52, for a total value of $31,940.16.
- On Tuesday, December 2nd, K Charles Janac sold 1,246 shares of Arteris stock. The stock was sold at an average price of $14.82, for a total value of $18,465.72.
- On Wednesday, October 8th, K Charles Janac sold 50,000 shares of Arteris stock. The shares were sold at an average price of $13.07, for a total value of $653,500.00.
Arteris Stock Performance
Shares of NASDAQ:AIP opened at $16.63 on Friday. The company’s fifty day moving average is $15.34 and its 200-day moving average is $12.08. Arteris, Inc. has a 52 week low of $5.46 and a 52 week high of $19.85. The company has a market capitalization of $726.40 million, a PE ratio of -20.04 and a beta of 1.48.
Hedge Funds Weigh In On Arteris
Large investors have recently made changes to their positions in the company. Raymond James Financial Inc. bought a new position in Arteris in the second quarter valued at about $32,000. BNP Paribas Financial Markets lifted its position in Arteris by 75.0% during the 3rd quarter. BNP Paribas Financial Markets now owns 6,053 shares of the company’s stock valued at $61,000 after purchasing an additional 2,595 shares during the period. Savant Capital LLC acquired a new position in Arteris during the 2nd quarter valued at about $97,000. Kapitalo Investimentos Ltda bought a new position in shares of Arteris in the 2nd quarter valued at about $104,000. Finally, Strs Ohio acquired a new stake in shares of Arteris during the 1st quarter worth approximately $104,000. Institutional investors and hedge funds own 64.36% of the company’s stock.
Arteris News Summary
Here are the key news stories impacting Arteris this week:
- Negative Sentiment: CEO K. Charles Janac sold 11,145 shares (avg. $16.90) on Jan. 6 — a ~7.4% reduction in his holding; large CEO sales often increase short-term selling pressure. CEO Sale SEC Filing
- Negative Sentiment: CFO Nicholas Hawkins sold a total of ~10,308 shares across early-Jan transactions (avg. prices ~$15.45–$17.27), trimming his stake by roughly 6–7% — another executive sale that can be perceived negatively by investors. CFO Sale SEC Filing
- Negative Sentiment: COO Laurent R. Moll sold ~6,793 shares in early January (multiple transactions, avg. ~$15.45–$16.23), reducing his holding by ~0.5–2% per filing — adds to the cluster of insider sales this week. COO Sale SEC Filing
- Negative Sentiment: VP Paul L. Alpern sold multiple tranches (~6,818 shares total; avg. ~$16.00–$16.89), reducing his stake by several percent — part of the same pattern of insider liquidity events. VP Sale SEC Filing
Analyst Ratings Changes
A number of equities research analysts recently commented on the company. Cowen restated a “buy” rating on shares of Arteris in a research report on Wednesday, November 5th. Rosenblatt Securities reissued a “buy” rating and issued a $20.00 price objective on shares of Arteris in a research note on Monday, December 15th. Weiss Ratings restated a “sell (d-)” rating on shares of Arteris in a research note on Wednesday, October 8th. Jefferies Financial Group raised Arteris to a “hold” rating in a report on Tuesday, October 28th. Finally, TD Cowen increased their price objective on shares of Arteris from $15.00 to $16.50 and gave the stock a “buy” rating in a report on Wednesday, November 5th. Four analysts have rated the stock with a Buy rating, one has given a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, Arteris currently has an average rating of “Moderate Buy” and a consensus price target of $17.50.
Arteris Company Profile
Arteris, Inc is a fabless semiconductor intellectual property (IP) company specializing in on-chip interconnect solutions and system IP for advanced integrated circuits. The company’s core products include its FlexNoC network-on-chip (NoC) fabrics, Ncore cache coherent interconnect IP, and CodaCache memory subsystem IP. These technologies enable semiconductor and systems companies to design scalable, energy-efficient chips for applications ranging from automotive and artificial intelligence (AI) to 5G communications and high-performance computing.
Founded in 2003 and headquartered in Santa Clara, California, Arteris serves a global customer base across North America, Europe, and Asia.
Featured Articles
- Five stocks we like better than Arteris
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
- Do not delete, read immediately
- This stock gets a 94 out of 100
- First Time Since 2007: All Warnings Active
- Executive Order 14330: Trump’s Biggest Yet
Receive News & Ratings for Arteris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arteris and related companies with MarketBeat.com's FREE daily email newsletter.
